We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
-$554M
Cap. Flow
-$798M
Cap. Flow %
-22.13%
Top 10 Hldgs %
9.27%
Holding
2,296
New
622
Increased
390
Reduced
675
Closed
586

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Consumer Discretionary 14.11%
3 Healthcare 13.6%
4 Industrials 12.95%
5 Financials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVAC
1601
DELISTED
Intevac Inc
IVAC
$132K ﹤0.01%
18,648
-42,092
-69% -$246K
EMKR
1602
DELISTED
Emcore Corp
EMKR
$129K ﹤0.01%
4,232
-4,172
-50% -$126K
EMWP
1603
DELISTED
Eros Media World PLC
EMWP
$126K ﹤0.01%
+1,861
New +$86.9K
GLRE icon
1604
Greenlight Captial
GLRE
$506M
$123K ﹤0.01%
+12,144
New +$126K
LQDA icon
1605
Liquidia Corp
LQDA
$8.02B
$120K ﹤0.01%
28,079
-47,810
-63% -$192K
BLU
1606
DELISTED
BELLUS Health Inc.
BLU
$120K ﹤0.01%
+15,781
New +$108K
GRBK icon
1607
Green Brick Partners
GRBK
$3.14B
$118K ﹤0.01%
+10,270
New +$112K
OPK icon
1608
Opko Health
OPK
$1.02B
$118K ﹤0.01%
+80,228
New +$134K
LAIX
1609
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$114K ﹤0.01%
+1,676
New +$82.9K
BTE icon
1610
Baytex Energy
BTE
$2.92B
$112K ﹤0.01%
77,390
+40,533
+110% +$50.1K
ALGRR
1611
DELISTED
Allegro Merger Corp Right
ALGRR
$112K ﹤0.01%
350,100
-1,853,522
-84% -$594K
AIOS
1612
AIOS Tech
AIOS
$39M
$111K ﹤0.01%
+96
New +$96K
TBIO
1613
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$110K ﹤0.01%
+13,551
New +$125K
NSLR
1614
Neostellar Capital Corp
NSLR
$254M
$109K ﹤0.01%
+19,907
New +$109K
LSAK icon
1615
Lesaka Technologies
LSAK
$420M
$108K ﹤0.01%
+29,075
New +$96.4K
KGC icon
1616
Kinross Gold
KGC
$32.8B
$105K ﹤0.01%
+22,182
New +$100K
SACH
1617
Sachem Capital Corp
SACH
$39.8M
$99K ﹤0.01%
22,784
-43,700
-66% -$195K
VSTM icon
1618
Verastem
VSTM
$610M
$99K ﹤0.01%
+6,144
New +$88.3K
LOACR
1619
DELISTED
Longevity Acquisition Corporation Right
LOACR
$97K ﹤0.01%
530,441
-49,980
-9% -$10.5K
HNRG icon
1620
Hallador Energy
HNRG
$696M
$96K ﹤0.01%
32,275
-20,638
-39% -$63.3K
SBBP
1621
DELISTED
Strongbridge Biopharma plc.
SBBP
$93K ﹤0.01%
44,640
+3,483
+8% +$6.68K
HEPA
1622
DELISTED
Hepion Pharmaceuticals
HEPA
$92K ﹤0.01%
+17
New +$65.8K
NIU
1623
Niu Technologies
NIU
$193M
$92K ﹤0.01%
+10,827
New +$96.8K
KLDO
1624
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$89K ﹤0.01%
+17,715
New +$113K
ARC
1625
DELISTED
ARC Document Solutions, Inc.
ARC
$88K ﹤0.01%
63,282
-129,374
-67% -$169K

Similar funds

Oxford Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Oxford Asset Management held 2,296 positions worth $3.6B, down 13% from $4.16B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Oxford Asset Management withdrew a net $798M in Q4 2019, closing 586 positions and reducing 675 holdings. Its most notable exit was Medidata Solutions, Inc., an estimated $48.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in WABCO HOLDINGS INC. worth $42M.

  • Oxford Asset Management's largest Q4 2019 buy was WABCO HOLDINGS INC.: 310,063 shares worth $42M.
  • Oxford Asset Management added most to China Biologic Products Holdings, Inc. in Q4 2019, an estimated $16.2M increase.
  • Oxford Asset Management's biggest Q4 2019 reduction was Intuit, cutting an estimated $22.5M.
  • Oxford Asset Management fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $48.1M.
  • Oxford Asset Management's ten largest holdings make up 9.3% of its $3.6B portfolio in Q4 2019.
  • Oxford Asset Management opened 622 new positions and closed 586 in Q4 2019.
  • Oxford Asset Management's portfolio value fell 13% quarter-over-quarter to $3.6B.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.